Former French president Nicolas Sarkozy yesterday became the first former head of an EU state to be jailed, proclaiming his innocence as he entered a Paris prison.
France’s right-wing leader from 2007 to 2012 was last month found guilty of seeking to acquire funding from former Libyan leader Muammar Qaddafi for the campaign that saw him elected.
Sarkozy, 70, left his home and after a short drive flanked by police on motorbikes, entered La Sante prison in the French capital.
Photo: Reuters
“Welcome Sarkozy,” “Sarkozy’s here,” convicts were heard shouting from their cells.
In a defiant message posted on social media as he was being transferred, Sarkozy denied any wrongdoing.
“It is not a former president of the republic being jailed this morning, but an innocent man,” he wrote on X.
“I have no doubt. The truth will prevail,” he added.
Sarkozy was on Sept. 25 handed a five-year jail term for criminal conspiracy over a plan for Qaddafi to fund his electoral campaign.
After the verdict, Sarkozy had said he would “sleep in prison — but with my head held high.”
Dozens of supporters and family members had stood outside the former president’s home from early yesterday, some holding up framed portraits of him.
“Nicolas, Nicolas! Free Nicolas,” they shouted as he left his home, holding hands with his wife, singer Carla Bruni.
Earlier they had sung the French national anthem, as neighbors looked on from their balconies.
“This is truly a sad day for France and for democracy,” said Flora Amanou, 41.
Sarkozy’s lawyer, Christophe Ingrain, said a request had been immediately filed for Sarkozy’s release.
The Paris appeals court in theory has two months to decide whether to free him pending an appeals trial, but the delay is usually shorter.
Sarkozy is the first French leader to be incarcerated since Philippe Petain, the Nazi collaborationist head of state who was jailed after World War II.
He told Le Figaro newspaper he would be taking with him a biography of Jesus and a copy of The Count of Monte Cristo.
Sarkozy is likely to be held in a 9m2 cell in the prison’s solitary confinement wing to avoid contact with other prisoners, prison staff said.
In solitary confinement, inmates are allowed out of their cells for one walk a day, alone, in a small yard. Sarkozy will also be allowed visits three times a week.
Sarkozy has faced a flurry of legal woes since losing his re-election bid in 2012.
He has also been convicted in two other cases.
In one, he served a sentence for graft — over seeking to secure favors from a judge — under house arrest while wearing an electronic ankle tag, which was removed after several months in May.
In another, France’s top court is to rule next month in a case in which he is accused of illegal campaign financing in 2012.
In the so-called “Libyan case,” prosecutors said his aides, acting in Sarkozy’s name, struck a deal with Qaddafi in 2005 to illegally fund his victorious presidential election bid two years later.
Investigators believe that in return, Qaddafi was promised help to restore his international image after Tripoli was blamed for the 1988 bombing of a passenger jet over Lockerbie, Scotland, and another over Niger in 1989, killing hundreds of passengers.
The court convicted him of criminal conspiracy over the plan, but it did not conclude that Sarkozy received or used the funds for his campaign.
It acquitted him on charges of embezzling Libyan public funds, passive corruption and illicit financing of an electoral campaign.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS